| |
|
|
|
AMAG Pharmaceuticals Inc.  
|
|
8.44 0.74 (0.1%) |
07-15 13:29 |
|
Open: |
7.95 |
Pre close: |
7.7 |
Target:
|
10.14 
|
|
High: |
8.53 |
Low: |
7.89 |
Resistance:
|
8.68
10.14
|
|
Volume: |
383,149 |
Market Cap: |
289M |
Support:
|
7.42
6.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.52
|
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
7.63 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
7.41  |
Stochastic Oscillator |
%K(14,3):
|
51.55 |
|
MA(250): |
9.43 |
%D(3): |
34.87 |
|
Average Volume(K) |
3-Month: |
55269
|
52-Week |
High:
|
13.53 |
|
10-Days: |
38352 |
Low: |
4.41 |
|
RSI |
RSI(14):
|
57.71 |
Change(%): |
-7.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-10.870 |
Return on Equity (ttm) |
-84.0 |
Shares Out. (M) |
34.27 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-7.9 |
Shares Float (M) |
16.73 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.74 |
|
EPS Est. Next Quarter |
0.270 |
Qtrly Rev. Growth |
-9.4 |
% Held by Institutions |
134.32 |
|
Forward EPS |
-13.710 |
Gross Profit (p.s.) |
5.220 |
Shares Short (K) |
12490 |
|
Book Value (p.s.) |
7.700 |
EBITDA (p.s.) |
-2.836 |
P/E |
-0.77 |
|
Sales Per Share |
9.355 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.08 |
|
Profit Margin |
-115.05 |
Operating Cash Flow
(M) |
-82.40 |
P/S |
0.89 |
|
Operating Margin |
-35.97 |
Levered Free Cash Flow
(M) |
-89.73 |
P/CF |
-3.47 |
|
|
|
|
|
|
